Trial Profile
Efficacy and Safety of Baricitinib in Rheumatoid Arthritis Patients Compared With Those Treated by Biologics or Tofacitinib
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 22 Sep 2021
Price :
$35
*
At a glance
- Drugs Baricitinib (Primary) ; Tofacitinib (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 20 Sep 2021 Planned End Date changed from 20 Nov 2023 to 20 Nov 2025.
- 20 Sep 2021 Planned primary completion date changed from 20 Nov 2021 to 20 Nov 2023.
- 10 Aug 2020 Planned primary completion date changed from 20 Nov 2019 to 20 Nov 2021.